Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 83 Results

March 14, 2019

Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

April 4, 2018

Surrozen Strengthens Leadership Team with Addition of New CEO and Scientific Co-founder

February 15, 2017

Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group

«...5 6 7 89

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

FCOI Policy
Accessibility

Scroll to Top